ApoB or Lp(a) came back high. What actually changes next?

What is ApoB?

ApoB, short for apolipoprotein B, is the protein wrapped around every cholesterol-carrying particle that can enter an artery wall. An ApoB test therefore counts those particles.

Each particle carries exactly one ApoB molecule, and cholesterol can only get into the artery wall inside these particles [PMID: 31642874]. LDL cholesterol, the familiar number, measures the cargo; ApoB counts the carriers. The two usually move together, but the amount of cholesterol per particle varies, so they can disagree, most often when triglycerides are high or when insulin resistance, a state in which cells respond poorly to insulin, is present. When they disagree, risk follows ApoB more closely, both before and during treatment [PMID: 39256087].

Time matters as much as level. Genetic studies, long-term cohorts and treatment trials covering more than two million people show cardiovascular risk rising with both the level of LDL in the blood and the number of years the arteries are exposed to it [PMID: 28444290]. How ApoB sits beside the other lines of an advanced lipid panel is a subject of its own.

What is a normal ApoB range?

There is no single normal ApoB range. A laboratory's reference range describes the general population, while the goal a physician sets depends on the person's risk: the higher the risk, the lower the goal.

A translation from LDL cholesterol helps. In a nationally representative sample of US adults not taking lipid-lowering medication, an LDL cholesterol of 100 mg/dL matched a typical ApoB of about 80 mg/dL, an LDL cholesterol of 70 matched about 60, and an LDL cholesterol of 55 matched about 49 [PMID: 38865115]. The same study shows why the direct measurement earns its place: among people whose LDL cholesterol was 100, ApoB ran from 66 to 99 mg/dL across the middle 95 percent. Some laboratories report in g/L, where 0.80 equals 80 mg/dL.

The 2026 US lipid guideline brought back treatment goals, with ApoB goals among them in select cases, set by risk category [PMID: 42295619]. A result is therefore read as high for this person's risk, not only as flagged by the laboratory.

How is ApoB lowered?

ApoB is lowered in two ways: changes in how a person eats and lives, and lipid-lowering medication. People with a clearly high level and meaningful risk often end up using both.

Food and activity come first. Replacing saturated fat with unsaturated fat, eating more viscous fiber from oats, beans and similar foods, losing excess weight around the middle, and cutting back alcohol and refined carbohydrate when triglycerides are high all reduce the number of particles. How far this goes depends heavily on genetics. For some people it is enough; for others it moves the number only modestly.

Medication does more of the work when risk is high or the level is inherited. The main classes help the liver clear particles from the blood faster, and they can be combined. The size of the benefit is well measured: across 26 randomized trials with about 170,000 participants, each 1 mmol/L reduction in LDL cholesterol, about 39 mg/dL, lowered the yearly rate of heart attacks, strokes and artery procedures by roughly a fifth [PMID: 21067804]. Genetic evidence suggests the benefit is proportional to the change in ApoB itself [PMID: 30694319].

A physician also looks for a reason behind a high ApoB. An underactive thyroid, kidney disease, some medications and the menopause transition can each raise it, and treating the cause can lower the number.

What is Lp(a), and why is it usually measured once?

Lp(a) is an LDL-like particle with an extra protein, apolipoprotein(a), attached. Its level is set mostly by genes and changes little through adult life, which is why one measurement is usually enough.

Between about 70 and more than 90 percent of the difference in Lp(a) between people is inherited [PMID: 34647487]. High levels are a causal risk factor for plaque in the arteries and for calcification and narrowing of the aortic valve, the heart's main outlet, and the relationship is continuous, with no sharp line between safe and unsafe [PMID: 36036785]. US guidance now recommends measuring Lp(a) at least once in adult life [PMID: 42295619]. Levels are stable but not perfectly fixed, so a result near a threshold is sometimes repeated [PMID: 41440551].

For the lipoprotein(a) normal range, lipid specialists use three zones. Below 75 nmol/L, or 30 mg/dL, is low risk. At or above 125 nmol/L, or 50 mg/dL, is high risk. Values in between are intermediate. About one person in five has an elevated level [PMID: 38565461].

Can lipoprotein(a) be lowered?

Not by much, with what is available today. Diet, exercise and the standard lipid-lowering medications have minimal effect on Lp(a) [PMID: 41684258], so a physician's attention moves to everything else that can be changed.

That is a strategy, not a consolation. The guidance for people with high Lp(a) is earlier and more intensive management of the other risk factors, LDL cholesterol above all, along with blood pressure, blood sugar and smoking [PMID: 38565461]. Lp(a) remains a risk factor even when LDL cholesterol and ApoB are well controlled [PMID: 34647487], which argues for taking the controllable numbers lower than would otherwise be needed.

Two other options sit at the edges. Lipoprotein apheresis, a procedure that filters the particles out of the blood on a regular schedule, is reserved for a small group with very high levels and progressing disease [PMID: 36036785]. New medicines that switch off production of the particle in the liver have lowered Lp(a) by as much as 80 to 90 percent in trials. As of 2026 none had been approved for that purpose, and the large studies testing whether they prevent heart attacks and strokes were still under way [PMID: 42099476].

What does a high ApoB or Lp(a) mean for family members?

Both can run in families, so one person's result is often useful information for parents, siblings and children.

Lp(a) is the clearer case. In a large UK study, nearly half of the first-degree relatives of people with high Lp(a) also had a high level, against about one in six unrelated people [PMID: 37819667], and lipid specialists advise offering the test to first-degree relatives [PMID: 38565461]. A very high ApoB or LDL cholesterol, especially with early heart disease in the family, raises the question of familial hypercholesterolemia, an inherited condition in which LDL is cleared slowly from birth. It affects roughly 1 in 300 people [PMID: 32439005], and identifying an inherited lipid condition in one person is a reason to test close relatives [PMID: 39256087].

What does a physician weigh before changing anything?

A physician weighs the result against the person's overall risk, because the same ApoB or Lp(a) can call for different plans in different people.

• The rest of the risk picture. Age, blood pressure, smoking, blood sugar and insulin markers, kidney function, inflammation, and any family history of early heart disease
• A calculated risk. Current US guidance starts from a calculated ten-year risk, adds a thirty-year estimate for adults aged 30 to 59, and weighs clinical and laboratory findings alongside it [PMID: 42295619]
• What the arteries already show. When the decision is close, a coronary calcium score shows whether calcified plaque has formed
• Whether the number is real and explained. A repeat measurement, a check for thyroid, kidney and medication causes, and the pattern across the whole lipid panel
• The person's own view. Preferences about medication, pregnancy plans, earlier side effects, and how much change in food and training is realistic

The outcome is a shared decision with a target, a timeline and a repeat test, and one physician who stays accountable for whether the plan worked.

When is prompt care needed?

A high ApoB or Lp(a) is never an emergency in itself; it describes risk over years. Symptoms are different. Chest pain or pressure, trouble breathing, fainting, or sudden weakness, numbness or trouble speaking is a reason to call 911 or go to the nearest emergency department. Chest tightness or unusual breathlessness that comes on with exertion deserves prompt medical evaluation, whatever the lipid numbers.

Can results from a test ordered without a physician be used?

Yes. ApoB and Lp(a) results from a panel a person ordered on their own are reviewed as part of care. The useful package is the full report with units and reference ranges, whether the sample was fasting, any earlier lipid panels, the medication and supplement list, and what is known about heart disease, stroke and cholesterol in close relatives, including the ages at which events happened.

The deeper picture

ApoB and Lp(a) answer different questions. ApoB says how many plaque-forming particles are in circulation now, and it responds to what a person does. Lp(a) describes part of the hand a person was dealt, and for now it mostly informs how carefully the other cards are played. Neither number is a forecast: many people with a high Lp(a) never have a cardiac event, and the modifiable share of risk is large. Turning two lab values into a proportionate plan that holds up over decades takes physician-level clinical rigor and follow-through, which is the approach taken at Extend Medical.